# RBOT (Vicarious Surgical Inc.) - SEC EDGAR Financial Statements

> Vicarious Surgical Inc. reported $19.58M in total assets and a net loss of $50.18M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RBOT
- Markdown: https://convexityos.com/fundamentals/RBOT.md
- SEC CIK: 0001812173
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001812173&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$50.03M | Operating profit |
| Net Income | FY 2025 | -$50.18M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -$45.21M | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | $9.79M | Total debt: $7.26M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $33.60M | $40.16M | $47.58M | $43.90M | $22.06M | $9.80M |
| Selling, General & Admin | $17.37M | $26.40M | $33.09M | $36.18M | $16.16M | $3.19M |
| Total Operating Expenses | $50.03M | $66.56M | $80.67M | $80.08M | $38.22M | $12.98M |
| **Operating Income** | -$50.03M | -$66.56M | -$80.67M | -$80.08M | -$38.22M | -$12.98M |
| **EBITDA** | -$48.60M | -$64.45M | -$78.81M | -$78.97M | -$37.91M | -$12.83M |
| Interest Income | -- | $3.29M | $4.43M | $1.44M | $20K | $113K |
| Interest Expense | -- | -- | $25K | $200K | $89K | $3.0K |
| Income Before Tax | -$50.18M | -$63.22M | -$71.07M | $5.16M | -$35.21M | -$12.88M |
| **Net Income** | -$50.18M | -$63.22M | -$71.07M | $5.16M | -$35.21M | -$12.88M |
| Basic EPS | -- | -- | -$14.71 | $1.20 | -$10.81 | -$4.80 |
| **Diluted EPS** | -- | -- | -$14.71 | $1.20 | -$10.81 | -$4.80 |
| Basic Shares Outstanding | 6.1M | 5.9M | 4.9M | 4.1M | 3.2M | -- |
| Diluted Shares Outstanding | 6.1M | 5.9M | 4.9M | 4.2M | 3.2M | 2.6M |

### Income Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $7.14M | $7.99M | $9.05M | $9.41M | $8.46M | $10.80M | $10.92M | $9.97M |
| Selling, General & Admin | $3.06M | $3.51M | $4.47M | $6.33M | $6.51M | $6.96M | $6.79M | $6.14M |
| Total Operating Expenses | $9.26M | $11.50M | $13.52M | $15.75M | $14.98M | $17.75M | $17.71M | $16.11M |
| **Operating Income** | -$9.26M | -$11.50M | -$13.52M | -$15.75M | -$14.98M | -$17.75M | -$17.71M | -$16.11M |
| **EBITDA** | -$8.97M | -$11.15M | -$13.11M | -$15.38M | -$14.44M | -$17.25M | -$17.19M | -$15.59M |
| Interest Income | -- | -- | $264K | $446K | -- | $802K | $918K | $975K |
| Income Before Tax | -$10.52M | -$11.06M | -$13.21M | -$15.39M | -$13.93M | -$17.09M | -$15.21M | -$17.00M |
| **Net Income** | -$10.52M | -$11.06M | -$13.21M | -$15.39M | -$13.93M | -$17.09M | -$15.21M | -$17.00M |
| Basic EPS | -- | -- | -- | -- | -- | -- | -$2.59 | -$3.00 |
| **Diluted EPS** | -- | -- | -- | -- | -- | -- | -$2.59 | -$3.00 |
| Basic Shares Outstanding | -- | 6.0M | 5.9M | 5.9M | -- | 5.9M | 5.9M | 5.9M |
| Diluted Shares Outstanding | -- | 6.0M | 5.9M | 5.9M | -- | 5.9M | 5.9M | 5.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.57M | $9.74M | $52.82M | $116.2M | $173.5M | $16.87M |
| Short-Term Investments | $7.22M | $39.36M | $45.35M | -- | -- | -- |
| **Cash & Short-Term Investments** | $9.79M | $49.10M | $98.18M | $116.2M | $173.5M | $16.87M |
| **Total Current Assets** | $11.58M | $51.70M | $101.0M | $120.4M | $178.4M | $17.12M |
| Property, Plant & Equipment, Net | $1.27M | $4.48M | $6.40M | $6.59M | $2.25M | $445K |
| Other Non-Current Assets | $29K | $49K | $114K | $92K | -- | $100K |
| **Total Non-Current Assets** | $8.00M | $16.02M | $18.91M | $19.89M | $3.31M | $663K |
| **Total Assets** | $19.58M | $67.72M | $119.9M | $140.3M | $181.7M | $17.79M |
| Accounts Payable | $894K | $1.17M | $1.26M | $1.73M | $1.50M | $373K |
| **Total Current Liabilities** | $3.90M | $7.67M | $7.28M | $8.39M | $6.25M | $814K |
| Long-Term Debt | -- | -- | $2.00M | -- | $675K | -- |
| **Total Non-Current Liabilities** | $5.84M | $13.35M | $14.62M | $20.85M | $92.34M | $121K |
| **Total Liabilities** | $9.74M | $21.02M | $21.89M | $29.25M | $98.59M | $935K |
| **Total Debt (incl. Leases)** | $7.26M | $13.79M | $16.83M | $30.50M | $675K | -- |
| Common Stock | -- | -- | -- | $11K | $10K | $7.0K |
| Retained Earnings | -$246.1M | -$195.9M | -$132.7M | -$61.64M | -$66.80M | -$31.59M |
| Accumulated Other Comp. Income | $4.0K | $50K | $10K | -- | -- | -- |
| **Total Stockholders' Equity** | $9.84M | $46.70M | $97.97M | $111.0M | $83.09M | -$29.82M |
| Total Equity | $9.84M | $46.70M | $97.97M | $111.0M | $83.09M | $16.85M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.57M | $3.16M | $3.91M | $2.60M | $9.74M | $7.07M | $20.25M | $38.22M |
| Short-Term Investments | $7.22M | $10.25M | $20.05M | $34.76M | $39.36M | $53.80M | $52.98M | $45.90M |
| **Cash & Short-Term Investments** | $9.79M | $13.41M | $23.96M | $37.36M | $49.10M | $60.86M | $73.23M | $84.13M |
| **Total Current Assets** | $11.58M | $15.07M | $26.07M | $39.65M | $51.70M | $63.98M | $75.93M | $87.11M |
| Property, Plant & Equipment, Net | $1.27M | $3.48M | $3.79M | $4.11M | $4.48M | $4.82M | $5.33M | $5.89M |
| Other Non-Current Assets | $29K | $39K | $21K | $31K | $49K | $89K | $132K | $105K |
| **Total Non-Current Assets** | $8.00M | $14.27M | $14.82M | $15.40M | $16.02M | $16.64M | $17.41M | $18.18M |
| **Total Assets** | $19.58M | $29.35M | $40.89M | $55.05M | $67.72M | $80.62M | $93.35M | $105.3M |
| Accounts Payable | $894K | $915K | $721K | $1.02M | $1.17M | $2.42M | $1.35M | $1.27M |
| **Total Current Liabilities** | $3.90M | $3.18M | $5.10M | $7.86M | $7.67M | $8.60M | $7.18M | $5.08M |
| **Total Non-Current Liabilities** | $5.84M | $12.08M | $12.73M | $13.12M | $13.35M | $14.13M | $14.30M | $16.20M |
| **Total Liabilities** | $9.74M | $15.26M | $17.83M | $20.98M | $21.02M | $22.73M | $21.49M | $21.28M |
| **Total Debt (incl. Leases)** | $7.26M | $12.89M | $13.20M | $13.50M | $13.79M | $14.06M | $14.33M | $14.59M |
| Retained Earnings | -$246.1M | -$235.6M | -$224.5M | -$211.3M | -$195.9M | -$182.0M | -$164.9M | -$149.7M |
| Accumulated Other Comp. Income | $4.0K | $8.0K | -- | $18K | $50K | $124K | -$51K | -$41K |
| **Total Stockholders' Equity** | $9.84M | $14.09M | $23.06M | $34.08M | $46.70M | $57.88M | $71.86M | $84.01M |
| Total Equity | $9.84M | $14.09M | $23.06M | $34.08M | $46.70M | $57.88M | $71.86M | $84.01M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$50.18M | -$63.22M | -$71.07M | $5.16M | -$35.21M | -$12.88M |
| Depreciation & Amortization | $1.43M | $2.11M | $1.85M | $1.11M | $316K | $157K |
| Stock-Based Compensation | $8.13M | $11.90M | $13.27M | $12.26M | $3.69M | $448K |
| Change in Payables | -$272K | -$96K | -$473K | $135K | $1.13M | -- |
| **Operating Cash Flow** | -$45.08M | -$49.96M | -$62.30M | -$61.21M | -$33.30M | -$12.04M |
| Capital Expenditure | -$132K | -$180K | -$1.67M | -$5.35M | -$1.29M | -$120K |
| **Free Cash Flow** | -$45.21M | -$50.14M | -$63.98M | -$66.56M | -$34.59M | -$12.16M |
| Acquisitions, Net | -- | -- | -- | -$1.20M | -- | -- |
| Purchases of Investments | -$21.34M | -$58.15M | -$75.70M | -- | -- | -- |
| **Investing Cash Flow** | $32.15M | $6.86M | -$45.78M | -$5.35M | -$1.29M | $13.20M |
| Common Stock Issued | -- | -- | $47.05M | $10.00M | -- | -- |
| **Financing Cash Flow** | $5.76M | $8.0K | $44.70M | $9.14M | $192.2M | $13.52M |
| **Net Change in Cash** | -$7.17M | -$43.09M | -$63.39M | -$57.42M | $157.6M | $14.68M |

### Cash Flow Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.52M | -$11.06M | -$13.21M | -$15.39M | -$13.93M | -$17.09M | -$15.21M | -$17.00M |
| Depreciation & Amortization | $291K | $352K | $413K | $369K | $542K | $507K | $524K | $521K |
| Stock-Based Compensation | $1.10M | $2.05M | $2.20M | $2.79M | $2.81M | $2.94M | $3.07M | $3.09M |
| Change in Payables | -$10K | $275K | -$392K | -$145K | -$233K | $40K | $83K | $14K |
| **Operating Cash Flow** | -$9.31M | -$10.46M | -$13.53M | -$11.77M | -$11.79M | -$12.69M | -$11.02M | -$14.46M |
| Capital Expenditure | -- | -- | $0 | -$5.0K | -- | -- | -$6.0K | -$10K |
| **Free Cash Flow** | -- | -- | -$13.53M | -$11.77M | -- | -- | -$11.03M | -$14.47M |
| Purchases of Investments | -$6.38M | -$3.95M | -$2.08M | -$8.93M | -$5.37M | -$13.89M | -$19.40M | -$19.49M |
| **Investing Cash Flow** | $3.02M | $9.69M | $14.82M | $4.61M | $14.45M | -$492K | -$6.95M | -$144K |
| **Financing Cash Flow** | $5.69M | $26K | $24K | $17K | $6.0K | $0 | $0 | $2.0K |
| **Net Change in Cash** | -$595K | -$746K | $1.31M | -$7.14M | $2.67M | -$13.18M | -$17.97M | -$14.60M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -509.9% | -135.4% | -72.5% | 4.6% | -42.4% | -- |
| Return on Assets (ROA) | -256.3% | -93.4% | -59.3% | 3.7% | -19.4% | -72.4% |
| Current Ratio | 2.97x | 6.74x | 13.87x | 14.35x | 28.56x | 21.04x |
| Quick Ratio | 2.51x | 6.40x | 13.49x | 13.85x | 27.78x | 20.72x |
| Debt to Equity | 0.74x | 0.30x | 0.17x | 0.27x | 0.01x | -- |
| **Net Income Growth (YoY)** | -- | -- | -1478.1% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -1325.0% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -509.9% | -380.4% | -258.5% | -180.8% | -135.4% | -107.8% | -84.9% | -72.8% |
| Return on Assets (ROA) | -256.3% | -182.6% | -145.8% | -111.9% | -93.4% | -77.4% | -65.4% | -58.1% |
| Current Ratio | 2.97x | 4.75x | 5.11x | 5.05x | 6.74x | 7.44x | 10.57x | 17.16x |
| Quick Ratio | 2.51x | 4.22x | 4.70x | 4.76x | 6.40x | 7.07x | 10.20x | 16.57x |
| Debt to Equity | 0.74x | 0.91x | 0.57x | 0.40x | 0.30x | 0.24x | 0.20x | 0.17x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
